Recent advances in preclinical multimodality imaging, including groundbreaking omni-tomography applications
Saturday, September 15, 2018
8:00 - 9:30 am
Room 612, Washington State Convention Center
Breakfast will be provided.
About this Workshop -
MILabs, a global innovation leader in the development of preclinical imaging instrumentation, will introduce a new-generation tomographic imaging platform utilizing proprietary detection and reconstruction methods for 3D/4D imaging of photon energies from 1eV up to 1 MeV. These broadband photon detection capabilities enable new high-resolution imaging applications for preclinical and basic biomedical research, including various novel capabilities for theranostics.
By using information of the full spectrum of gamma photons, PET and SPECT images can be acquired at unprecedented high resolutions, even for PET isotopes that exhibit positron ranges of several mm’s such as 82Rb, 86Y, 76Br and 124I. Moreover, photon energy discrimination enables for the first time, omni-tomography applications – the simultaneous imaging of both multiple PET isotopes as well as co-injected PET/SPECT tracers. Efficient imaging of lower-energy X-ray photons further enhances the platform with low-dose CT, dual-energy DCE-CT and attenuation-corrected tomography for near-infrared optical photon applications, allowing for any combination of stand-alone or fully integrated 3D/ 4D PET, SPECT, Optical and X-ray tomography.
- Prof. Frederik Beekman, TU Delft and Founder/CEO MILabs B.V.
- Kah Whye Peng, Ph.D., Mayo-Clinic and Imanis Life Sciences
- Felix Gremse, Ph.D., RWTH Aachen University Clinic
The MILabs Industry Workshop is free to all registered attendees of the WMIC 2018. You may sign up for the workshop as part of your WMIC registration.